# Silexon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/silexon

- Industry: Pharmaceuticals
- Headquarters: Nanjing, China
- Website: www.silexon.tech
- Total disclosed funding: $16M
- Latest round: Series A (Sep 7, 2021)
- Investors on record: 7

## About

Established in 2018 and based in Nanjing, China, Silexon is a pharmaceutical service provider that engages in the development of pharmaceutical with usage of artificial intelligence and big data technology.
 
The company focuses on the development of artificial intelligence pharmaceutical platform. Its main products include AI4D™ platform and AI4Pat™ platform. AI4D™ platform provides drug discovery, design and development services.

## Funding rounds

- Series A, Sep 7, 2021, $16M — Hong Shan, Eight Roads Ventures, MSA Capital, Quan Capital
- Series A, Nov 23, 2019 — MSA Capital, Prosperico Ventures, Turing Capital, Ascendin Fund
- Series A, Oct 17, 2019 — Prosperico Ventures, Ascendin Fund

## Investors

- Prosperico Ventures (https://capitalatlas.ai/funds/prosperico-ventures) — Series A
- Ascendin Fund (https://capitalatlas.ai/funds/ascendin-fund) — Series A
- MSA Capital (https://capitalatlas.ai/funds/msa-capital) — Series A
- Turing Capital (https://capitalatlas.ai/funds/turing-capital) — Series A
- Hong Shan — Series A
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A
- Quan Capital (https://capitalatlas.ai/funds/quan-capital) — Series A